1st World Congress
The 1st Theranostics World Congress (1TWC) on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT) took place on June 23-26, 2011 in Bad Berka, Germany. This Congress, co-organised by the Department of Nuclear Medicine/PET Center, Zentralklinik Bad Berka and the Institute of Nuclear Chemistry, Johannes Gutenberg University, Mainz, was targeted to chemists, physicians, and investigators dealing with generators, PET radiochemistry as well as molecular imaging and radionuclide therapy.
The Congress attracted over 400 participants from 53 countries coming from all 5 continents. In addition to the official program, there were a number of social and cultural events. The Congress organizers have provided access to audio and video recordings of the three day event that was expertly recorded by ITR8. Please click here to be taken to the presentation site. Click on the following links to access the summary slides or abstracts. To acces the orginal 1TWC website click here.
2nd World Congress
Over 500 medical professionals attended the 2nd Theranostics World Congress (2TWC) on Ga68 and Radiotherapy that was held in Chandigarh India, February 28 - March 2, 2013. Over the course of 3 days over 100 presentations and posters were presented reflecting the current usage of Ga68 and PRRT around the world as well as new and exciting development that have taken place since the 1st world congress in 2011. The abstracts for this conference as well as for the 22nd Singapore Nuclear Review are available free of charge at the World Journal of Nuclear Medicine.
2TWC saw advancement in using GA68 as a tracer for infection and inflammation as well as for receptor positive forms of breast and prostate cancer in addition to its use as a tracer for NET patients. Guidelines for patient safety for outpatient LU177 treatment were presented by Fremantle Hospital in Australia.